GlassScriptPhysician profile
Jamie Udwadia
NPI 1255476636
$2,435.08
in general payments reported to CMS, 2019-2025
31 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $226 · 2021: $219 · 2022: $375 · 2023: $370 · 2024: $311 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $922.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $950.01 | 2019-2025 | Grafix Pl, Grafix, Collagenase Santyl |
| Organogenesis INC. | $289.58 | 2022-2024 | Puraply |
| Collegium Pharmaceutical, INC. | $173.90 | 2019-2022 | |
| Next Science LLC | $126.61 | 2023 | Blastx, Xperience, Surgx |
| Mimedx Group, INC. | $100.49 | 2024-2025 | |
| Solventum Corporation | $91.88 | 2024-2025 | Activ.A.C. |
| Osiris Therapeutics INC. | $85.98 | 2019 | |
| Integra Lifesciences Corporation | $71.64 | 2024 | Tcc-Ez |
| Kerecis Limited | $62.13 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Kci USA, INC. | $52.96 | 2021-2023 | Activ.A.C. |
| Urgo Medical North America, LLC | $44.68 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Ovik Health, LLC | $35.21 | 2021 | |
| Pfizer INC. | $35.14 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $32.76 | 2021-2025 | Nuzyra |
| Takeda Pharmaceuticals U.S.A., INC. | $30.65 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $25.21 | 2019 | |
| Aroa Biosurgery Incorporated | $24.08 | 2024 | |
| Allergan, INC. | $19.12 | 2019 | |
| Cashflow Solutions, LLC | $18.33 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Daiichi Sankyo INC. | $18.27 | 2019 | |
| Tactile Systems Technology INC | $18.21 | 2019 | |
| Abbvie INC. | $16.62 | 2022 | |
| Tei Medical INC. | $15.39 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.36 | 2022 | |
| Pernix Therapeutics Holdings, INC. | $14.41 | 2019 | |
| Stryker Corporation | $13.92 | 2022 | |
| Hartmann USA, INC. | $13.72 | 2024 | Zetuvit Plus 10x10 P10 |
| Arbor Pharmaceuticals, INC. | $12.71 | 2019 | |
| Shionogi INC | $11.87 | 2019 | |
| Advanced Oxygen Therapy INC. | $8.64 | 2025 | Topical Oxygen Chamber For Extremities |
| Polarityte, INC. | $5.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Udwadia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.